MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$35M
Free Cash flow
$867M
Unit: Million (M) dollars
Positive Cash Flow Breakdown
Net income including noncontroll...
Accounts payable and other worki...
Restructuring and termination be...
Others
Negative Cash Flow Breakdown
Dividends paid
Purchases of treasury shares
Short-term borrowing (repayment)...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net income including noncontrolling interests
720
681
-5
767
Depreciation and amortization
155
156
173
158
Erisa litigation matter
0
0
0
0
Restructuring and termination benefits, net of cash
67
165
8
-2
Stock-based compensation expense
38
40
28
72
Goodwill and intangible assets impairment charges
-
-
919
-
Deferred income taxes
3
-18
-117
25
Receivables
59
215
-164
28
Inventories
69
41
-100
-6
Accounts payable and other working capital
135
-11
251
-
Accounts payable and other accruals
-
-
-
278
Other non-current assets
-28
-19
-35
-
Other non-current assets and liabilities
-
-
-
15
Other non-current liabilities
-23
-29
-95
-
Net cash provided by (used in) operations
995
747
1,453
1,261
Capital expenditures
128
138
177
155
Purchases of marketable securities and investments
54
70
161
153
Proceeds from sale of marketable securities and investments
56
94
244
158
Payment for acquisition, net of cash acquired
0
-
0
0
Other investing activities
-4
8
9
4
Net cash provided by (used in) investing activities
-122
-122
-103
-154
Short-term borrowing (repayment) less than 90 days, net
-85
1,138
-1,128
169
Principal payments of debt
4
1,082
0
516
Proceeds from issuance of debt
0
-
691
0
Dividends paid
462
417
523
420
Purchases of treasury shares
291
306
406
288
Proceeds from exercise of stock options
11
127
18
18
Other financing activities
-20
-23
-13
9
Net cash provided by (used in) financing activities
-851
-563
-1,361
-1,028
Effect of exchange rate changes on cash and cash equivalents
13
-15
20
-15
Net increase (decrease) in cash and cash equivalents
35
47
9
64
Cash and cash equivalents at beginning of the period
1,335
1,288
1,112
1,112
Cash and cash equivalents at end of the period
1,370
1,335
1,288
1,279
Page 1
Unit: Million (M) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Net income
including noncontrolling...
$720M
(-6.86%↓ Y/Y)
Depreciation and
amortization
$155M
(2.65%↑ Y/Y)
Accounts payable and
other working capital
$135M
Restructuring and termination
benefits, net of cash
$67M
(1216.67%↑ Y/Y)
Stock-based compensation
expense
$38M
(18.75%↑ Y/Y)
Other non-current
assets
-$28M
Deferred income taxes
$3M
(-57.14%↓ Y/Y)
Net cash provided by
(used in) operations
$995M
(12.56%↑ Y/Y)
Effect of exchange rate
changes on cash and cash...
$13M
(-55.17%↓ Y/Y)
Canceled cashflow
$151M
Net increase
(decrease) in cash and cash...
$35M
(-66.02%↓ Y/Y)
Canceled cashflow
$973M
Inventories
$69M
(177.53%↑ Y/Y)
Receivables
$59M
(368.18%↑ Y/Y)
Other non-current
liabilities
-$23M
Proceeds from exercise of
stock options
$11M
(-56.00%↓ Y/Y)
Proceeds from sale of
marketable securities and...
$56M
(-77.87%↓ Y/Y)
Other investing
activities
-$4M
(-233.33%↓ Y/Y)
Net cash provided by
(used in) financing...
-$851M
(-108.07%↓ Y/Y)
Net cash provided by
(used in) investing...
-$122M
(69.58%↑ Y/Y)
Canceled cashflow
$11M
Canceled cashflow
$60M
Dividends paid
$462M
(-2.53%↓ Y/Y)
Purchases of treasury
shares
$291M
(25.43%↑ Y/Y)
Short-term borrowing
(repayment) less than 90...
-$85M
(56.19%↑ Y/Y)
Other financing
activities
-$20M
(-119.23%↓ Y/Y)
Capital expenditures
$128M
(18.52%↑ Y/Y)
Principal payments of debt
$4M
(-97.04%↓ Y/Y)
Purchases of marketable
securities and investments
$54M
(-78.40%↓ Y/Y)
Buy us a coffee
Colgate-Palmolive_logo-svg
COLGATE PALMOLIVE CO (CL)
Colgate-Palmolive_logo-svg
COLGATE PALMOLIVE CO (CL)
Show more